News
WaveClear, Inc. announces the closing of a $1,125,000 Series-A round of investment led by Hunniwell Lake Ventures. They will use their funds to further develop the CaviClearTM Endovascular System, a minimally invasive and cost-effective ultrasound generated cavitation device for a broad range of endovascular applications. Read More ⇒
THE LATEST
Meet the Founding Members of CoapTech
CoapTech Co-Founders CEO Howard Carolan and CMO Steve Tropello share their journey founding CoapTech and developing the novel PUMA system in order to relieve patient suffering and improve quality.
ViviMedia Interviews Richard Fang at F50 Global Capital Summit
HLV Founding Managing Partner Richard Fang shares his personal entrepreneurial experience, as well as the motivation and the differentiating strategies behind the Hunniwell Medical Device Fund.
Breakthroughs in Gastrointestinal Surgery
Hunniwell Lake Ventures shares key insights on the future of the rapidly growing Gastrointestinal medical device market.
WaveClear Raises $1.125 Million in Series A Funding Led by Hunniwell
WaveClear, Inc. announces the closing of a $1,125,000 Series-A round of investment led by Hunniwell Lake Ventures. They will use their funds to further develop the CaviClearTM Endovascular System, a minimally invasive and cost-effective ultrasound generated cavitation device for a broad range of endovascular applications.
How Energy-Based Devices are Transforming Medicine
Energy-based surgical devices are shifting the medical device industry. Hunniwell explores its various applications, benefits, and technological challenges that accompany its rising usage.
CoapTech Raises $7M in Series B Funding Led by Hunniwell
CoapTech has closed a Series B investment of $7 million led by Hunniwell. The funds will be used to commercialize the First FDA-cleared, Ultrasound-based system for Feeding Tube Placement.
Hunniwell Lake Ventures (HLV) is a Palo Alto-based VC firm that invests exclusively in medical devices. Its mission is to make surgery safer, more accessible and less invasive by investing in innovations that help surgeons visualize the operative field better, employ surgical tools using improved and advanced technologies to treat the patient, and ensure their speedy recovery through the best wound closure and tissue healing technologies available.
